AI Chipmaker Groq Chases Financial Risk Firms
Groq Accelerates COVID Drug Discovery 333x Versus Legacy Solutions, Enabling Developer Velocity at Argonne National Laboratory
In early 2020, Argonne National Laboratory started collaborating with scientists from around the world to fight the SARS-CoV-2 virus with accelerated drug discovery. Using artificial
Groq Attracts Industry Best from Fortune 500 Companies and Beyond
Market growth and innovation in the compute landscape offer refreshing opportunities for top talent who want to win at Groq
